Related Experiment Videos
Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract
Philipp Schuetz1, Matthias Briel, Beat Mueller
1Medical University Department, Kantonsspital Aarau, Tellstrasse, CH-5001 Aarau, Switzerland. schuetzph@gmail.com
Clinical Question:
In patients with respiratory tract infection, is measurement of procalcitonin to guide antibiotic prescriptions associated with reduced antibiotic exposure without increases in all-cause mortality or treatment failure?
Bottom Line:
The measurement of procalcitonin to guide initiation and duration of antibiotic treatment in patients with respiratory tract infections of varying severity is associated with lower antibiotic exposure without increasing all-cause mortality or treatment failure.
Related Concept Videos
Pneumonia III: Complications and Assessment
Atypical Pneumonia
Acute Pyelonephritis II: Diagnostic Studies and Management
Clinical Significance of Antibiotic Resistance
Urine Studies II: Urine Culture and Sensitivity Test
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: